Johnson and Johnson is now in direct control of manufacturing at a Baltimore contractor site. Yesterday, J&J announced it is in control of manufacturing at Emergent BioSolutions where 15-million doses of COVID-19 vaccine were ruined last week. In a statement yesterday, J&J said changes have been made to “operations and quality” at Emergent.